Abstract:Numerous molecular and physiological processes in the skeletal muscle undergo circadian time-dependent oscillations in accordance with daily activity/rest cycles. The circadian regulatory mechanisms underlying these cyclic processes, especially at the post-transcriptional level, are not well defined. Previously, we reported that the circadian E3 ligase FBXL21 mediates rhythmic degradation of the sarcomere protein TCAP in conjunction with GSK-3β, and Psttm mice harboring an Fbxl21 hypomorph allele show reduced muscle fiber diameter and impaired muscle function. To further elucidate the regulatory function of FBXL21 in skeletal muscle, we investigated another sarcomere protein, Myozenin1 (MYOZ1), that we identified as an FBXL21-binding protein from yeast 2-hybrid screening. We show that FBXL21 binding to MYOZ1 led to ubiquitination-mediated proteasomal degradation. GSK-3β co-expression and inhibition were found to accelerate and decelerate FBXL21-mediated MYOZ1 degradation, respectively. Previously, MYOZ1 has been shown to inhibit calcineurin/NFAT signaling important for muscle differentiation. In accordance, Fbxl21 KO and MyoZ1 KO in C2C12 cells impaired and enhanced myogenic differentiation respectively compared with control C2C12 cells, concomitant with distinct effects on NFAT nuclear localization and NFAT target gene expression. Importantly, in Psttm mice, both the levels and diurnal rhythm of NFAT2 nuclear localization were significantly diminished relative to wild-type mice, and circadian expression of NFAT target genes associated with muscle differentiation was also markedly dampened. Furthermore, Psttm mice exhibited significant disruption of sarcomere structure with a considerable excess of MYOZ1 accumulation in the Z-line. Taken together, our study illustrates a pivotal role of FBXL21 in sarcomere structure and muscle differentiation by regulating MYOZ1 degradation and NFAT2 signaling. Skeletal muscle is a vital organ for our mobility, metabolism, and health. It is also highly dynamic at the molecular level, yet the underlying regulatory mechanisms are not well understood. Mounting evidence suggests a critical role of the biological timer, called circadian clock, in the molecular flux during the daily activity/rest cycle. Our previous research has revealed a circadian E3 ubiquitin ligase, FBXL21, as a regulator in the skeletal muscle. In the current study, we provide molecular and genetic evidence that FBXL21, with its upstream regulator GSK-3β, regulates degradation of a sarcomere protein, MYOZ1. Consistent with a key regulatory function, FBXL21 deficiency in Psttm mice and C2C12 cells led to marked abnormalities in muscle differentiation and function. Mechanistically, we show that FBXL21 and MYOZ1 regulate diurnal NFAT nuclear translocation and activity, a pathway important for muscle differentiation and development. Together, our work establishes a critical role of the circadian E3 ligase FBXL21 in muscle differentiation and sarcomere structure by regulating MYOZ1 and NFAT signaling.

KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination.

Disrupting of E79 and K138 Interaction is Responsible for Human Muscle Creatine Kinase Deficiency Diseases

Defects in integrin complex formation promote CHKB-mediated muscular dystrophy

Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle

Ubiquitin Carboxyl-Terminal Hydrolase L1 is Required for Maintaining the Structure and Function of the Neuromuscular Junction.

N -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function

MYBPHL nonsense mutations have poor sarcomere binding, are degraded, and cause abnormal contraction

474 Stabilizing Mutations of KLHL24 Ubiquitin Ligase Cause Loss of Keratin 14 and Human Skin Fragility

14-3-3 Proteins Interact with Neurofilament Protein-L and Regulate Dynamic Assembly of Neurofilaments

Bi-allelic mutations in MYL1 cause a severe congenital myopathy

Kinesin light chain 1 stabilizes insulin receptor substrate 1 to regulate the IGF-1-AKT signaling pathway during myoblast differentiation

Systemic effect of FHL1 on neuromuscular junction and myotube formation via insulin-like growth factor and myostatin signaling pathways

NEKL-4 regulates microtubule stability and mitochondrial health in ciliated neurons

Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A/C-deficient mice

Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations

The circadian E3 ligase FBXL21 regulates myoblast differentiation and sarcomere architecture via MYOZ1 ubiquitination and NFAT signaling

Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variant

Protein kinase 2 of the giant sarcomeric protein UNC-89 regulates mitochondrial morphology and function

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia